Corinne Maurice‐Dror

BC Cancer Agency — Canada

Medicine · Health Sciences

15h-index1.1kcitations121works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(34), Cancer Genomics and Diagnostics(31), Bladder and Urothelial Cancer Treatments(29), Prostate Cancer Treatment and Research(29), Peptidase Inhibition and Analysis(15)

Publications120 total

Figure 1 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Figure 2 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Figure 3 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Table 1 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Figure 4 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Figure 5 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Table 2 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
2025Open Access
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer
Annals of Oncology·2025· 1 citedOpen Access
Bridging historical evidence and contemporary strategies in the adjuvant treatment of early-stage epithelial ovarian cancer
International Journal of Gynecological Cancer·2025Open Access
Supplementary Figure 8 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 8 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Figure 7 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 14 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Figure 5 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Data from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Figure 2 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 11 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 3 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 5 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
Supplementary Table 13 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
2025Open Access
page 1 of 6Next →

Frequent Co-authors

Kim N.(15), Alexander W. Wyatt(15), Cameron Herberts(13), Lucia Nappi(10), Bernhard J. Eigl(10), Matti Annala(10), Hyun Cheol Chung(9), Cecily Q. Bernales(9), Gráinne Donnellan(9), Christian Kollmannsberger(9), Ravit Geva(8), Ruth Perets(8), Gillian Vandekerkhove(8), Drew Rasco(7), Karan Parekh(7), Güliz Özgün(7), Edmond M. Kwan(6), Krista Noonan(6), Daygen L. Finch(6), Carlos Gomez‐Roca(6)